|
Recursion and Google Cloud Announce Expansion of Partnership to Support Drug Discovery with Cloud and Exploration of Generative AI Technologies
Friday, October 25, 2024
SALT LAKE CITY and SUNNYVALE, Calif., Oct. 21, 2024 /PRNewswire/ -- Recursion, a leading TechBio company decoding biology to radically improve lives, and Google Cloud today announced an expanded collaboration leveraging Google Cloud's technologies to support Recursion's drug discovery platform.
This strategic partnership includes exploring generative AI capabilities, including Gemini models, to support the RecursionOS, drive improved search and access with BigQuery, and help scale compute resources. In addition, Recursion will also explore making some of its AI models available on Google Cloud. The enriched partnership supports Recursion's ongoing effort to tackle the biopharmaceutical industry's critical challenge of slow and costly drug development by reducing the time and cost involved in bringing new therapies to patients--ushering in a new era of accessible and affordable healthcare globally.
The average cost to develop a new drug has increased by 15% in the past year, reaching approximately $2.3 billion, according to Deloitte. This increased expense and time-to-market limits the number of new therapies available to patients and contributes to the rising cost of healthcare. Recursion is addressing this problem by leveraging its own proprietary datasets, and AI tools, compute power, and advanced technologies from Google Cloud to accelerate drug discovery research. By streamlining the drug development process and increasing its success rate, Recursion seeks to revolutionize the industry and bring new, life-saving treatments to patients faster and more affordably.
"Our partnership with Google Cloud supports the acceleration of our research with a goal of bringing new and better treatments to patients more efficiently," said Chris Gibson, co-founder and CEO, Recursion. "We are pleased to have Google Cloud help us continue to push the boundaries of drug discovery and the development of new treatments for patients faster than ever before using their cloud infrastructure."
The two companies have a history of successful collaboration, working together for more than six years. To date, Google Cloud has provided infrastructure and services, including Google Kubernetes Engine (GKE), Google Compute Engine, Cloud storage of Recursion's massive datasets, and BigQuery, enabling Recursion to manage its biology and chemistry datasets, and complex computations involved in extracting insights from this data using its foundation models. This powerful application of AI has already accelerated Recursion's drug discovery, increasing the speed and lowering the cost to IND studies.
"We can help unlock the complexities of biology through the use of cutting-edge AI tools," said Thomas Kurian, CEO, Google Cloud. "Through our partnership with Recursion, we're supporting the discovery of novel therapeutics by combining Recursion's vast biological dataset and its own AI capabilities with the opportunity to explore our advanced AI and other technologies. Our goal is for this to not only deepen our scientific understanding, but also pave the way for a future where new treatments for complex diseases are developed faster and more efficiently for patients worldwide."
This expanded partnership will further enhance Recursion's ability to innovate and bring new treatments to patients faster, including:
-- Exploration of Gemini to support the RecursionOS and making some
Recursion models available on Google Cloud: As Recursion's preferred AI
cloud partner, the company will have access to Google Cloud's Gemini
family of models. Recursion's team will explore Gemini's capabilities
across multiple drug discovery efforts. In addition, Recursion will also
explore making some of its AI models available on Google Cloud.
-- Search and access: By using Google Cloud BigQuery, Recursion will be
able to query its industry-leading proprietary dataset at unprecedented
speed. It will enable Recursion's team to quickly identify important
data points from petabytes of data, improving the overall output and
efficiency.
-- Scale resources: Recursion will be able to quickly deploy computing
resources to run large inference workflows, bursting when needed beyond
its current GPU footprint. This will allow Recursion to scale its
computing resources and iterate on its models for drug discovery at an
accelerated pace.
-- Managing petabytes of data: Google Cloud storage will serve as
Recursion's main source of truth for its ever growing data set of
proprietary biological data. With Google Cloud, Recursion will be able
to effectively store, manage and transform information so its
scientists, engineers, and developers can effectively locate and use
needed datasets.
-- Continued data privacy and security support: Recursion meets rigorous
data security, compliance, and privacy standards to manage sensitive and
proprietary data at a large scale. In addition, Google Cloud customers
own their data, and all customer data is encrypted by default.
About Recursion
Recursion is a leading techbio company decoding biology to radically improve lives. By leveraging advanced technologies and massive datasets, Recursion aims to build a next-generation biopharmaceutical company that can develop new drugs faster and more efficiently.
About Google Cloud
Google Cloud is the new way to the cloud, providing AI, infrastructure, developer, data, security, and collaboration tools built for today and tomorrow. Google Cloud offers a powerful, fully integrated and optimized AI stack with its own planet-scale infrastructure, custom-built chips, generative AI models and development platform, as well as AI-powered applications, to help organizations transform. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner.
View original content to download multimedia:https://www.prnewswire.com/news-releases/recursion-and-google-cloud-announce-expansion-of-partnership-to-support-drug-discovery-with-cloud-and-exploration-of-generative-ai-technologies-302281509.html
SOURCE Google Cloud
|
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
|
|
|
